397 related articles for article (PubMed ID: 18698022)
1. High expression of neuropeptide Y1 receptors in ewing sarcoma tumors.
Körner M; Waser B; Reubi JC
Clin Cancer Res; 2008 Aug; 14(16):5043-9. PubMed ID: 18698022
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y receptors in primary human brain tumors: overexpression in high-grade tumors.
Körner M; Reubi JC
J Neuropathol Exp Neurol; 2008 Aug; 67(8):741-9. PubMed ID: 18648328
[TBL] [Abstract][Full Text] [Related]
3. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.
Modin A; Malmström RE; Meister B
Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification.
Reubi JC; Waser B; Laissue JA; Gebbers JO
Cancer Res; 1996 Apr; 56(8):1922-31. PubMed ID: 8620515
[TBL] [Abstract][Full Text] [Related]
5. NPY receptors in human cancer: a review of current knowledge.
Körner M; Reubi JC
Peptides; 2007 Feb; 28(2):419-25. PubMed ID: 17223228
[TBL] [Abstract][Full Text] [Related]
6. Preferential expression of the neuropeptide Y Y1 over the Y2 receptor subtype in cultured hippocampal neurons and cloning of the rat Y2 receptor.
St-Pierre JA; Dumont Y; Nouel D; Herzog H; Hamel E; Quirion R
Br J Pharmacol; 1998 Jan; 123(2):183-94. PubMed ID: 9489605
[TBL] [Abstract][Full Text] [Related]
7. High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paraganglia.
Körner M; Waser B; Reubi JC
Clin Cancer Res; 2004 Dec; 10(24):8426-33. PubMed ID: 15623622
[TBL] [Abstract][Full Text] [Related]
8. Effect of axotomy on expression of NPY, galanin, and NPY Y1 and Y2 receptors in dorsal root ganglia and the superior cervical ganglion studied with double-labeling in situ hybridization and immunohistochemistry.
Landry M; Holmberg K; Zhang X; Hökfelt T
Exp Neurol; 2000 Apr; 162(2):361-84. PubMed ID: 10739642
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor: a therapeutic target for tumors of the Ewing's sarcoma family.
Dalal S; Berry AM; Cullinane CJ; Mangham DC; Grimer R; Lewis IJ; Johnston C; Laurence V; Burchill SA
Clin Cancer Res; 2005 Mar; 11(6):2364-78. PubMed ID: 15788688
[TBL] [Abstract][Full Text] [Related]
10. Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting.
Reubi C; Gugger M; Waser B
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):855-62. PubMed ID: 12111125
[TBL] [Abstract][Full Text] [Related]
11. Evidence for activation of KIT, PDGFRalpha, and PDGFRbeta receptors in the Ewing sarcoma family of tumors.
Bozzi F; Tamborini E; Negri T; Pastore E; Ferrari A; Luksch R; Casanova M; Pierotti MA; Bellani FF; Pilotti S
Cancer; 2007 Apr; 109(8):1638-45. PubMed ID: 17342771
[TBL] [Abstract][Full Text] [Related]
12. Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets.
Reubi JC; Gugger M; Waser B; Schaer JC
Cancer Res; 2001 Jun; 61(11):4636-41. PubMed ID: 11389101
[TBL] [Abstract][Full Text] [Related]
13. Expression of neuropeptide Y receptors mRNA and protein in human brain vessels and cerebromicrovascular cells in culture.
Abounader R; Elhusseiny A; Cohen Z; Olivier A; Stanimirovic D; Quirion R; Hamel E
J Cereb Blood Flow Metab; 1999 Feb; 19(2):155-63. PubMed ID: 10027771
[TBL] [Abstract][Full Text] [Related]
14. Characterization of receptors for growth hormone-releasing hormone in human osteosarcomas and Ewing's sarcomas.
Halmos G; Schally AV; Bernardino AL; Varga JL
Int J Oncol; 2006 Aug; 29(2):463-9. PubMed ID: 16820890
[TBL] [Abstract][Full Text] [Related]
15. Change in the expression of NPY receptor subtypes Y1 and Y2 in central and peripheral neurons related to the control of blood pressure in rats following experimental hypertension.
Coelho EF; Ferrari MF; Maximino JR; Fior-Chadi DR
Neuropeptides; 2004; 38(2-3):77-82. PubMed ID: 15223269
[TBL] [Abstract][Full Text] [Related]
16. Expression of podoplanin in human bone and bone tumors: New marker of osteogenic and chondrogenic bone tumors.
Ariizumi T; Ogose A; Kawashima H; Hotta T; Li G; Xu Y; Umezu H; Sugai M; Endo N
Pathol Int; 2010 Mar; 60(3):193-202. PubMed ID: 20403045
[TBL] [Abstract][Full Text] [Related]
17. High expression of NPY receptors in the human testis.
Körner M; Waser B; Thalmann GN; Reubii JC
Mol Cell Endocrinol; 2011 Apr; 337(1-2):62-70. PubMed ID: 21295110
[TBL] [Abstract][Full Text] [Related]
18. Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells.
Lollini PL; Landuzzi L; Frabetti F; Rossi I; Nicoletti G; Scotlandi K; Serra M; Baldini N; De Giovanni C; Nanni P
Clin Cancer Res; 1998 Aug; 4(8):1843-9. PubMed ID: 9717810
[TBL] [Abstract][Full Text] [Related]
19. Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways.
de Hooge AS; Berghuis D; Santos SJ; Mooiman E; Romeo S; Kummer JA; Egeler RM; van Tol MJ; Melief CJ; Hogendoorn PC; Lankester AC
Clin Cancer Res; 2007 Jan; 13(1):206-14. PubMed ID: 17200356
[TBL] [Abstract][Full Text] [Related]
20. Procholecystokinin as marker of human Ewing sarcomas.
Reubi JC; Koefoed P; Hansen Tv; Stauffer E; Rauch D; Nielsen FC; Rehfeld JF
Clin Cancer Res; 2004 Aug; 10(16):5523-30. PubMed ID: 15328192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]